Table:
begin	end	state
1	26	signal peptide
27	274	non-cytoplasmic
275	302	transmembrane
303	306	cytoplasmic
307	324	transmembrane
325	328	non-cytoplasmic
329	350	transmembrane
351	361	cytoplasmic
362	380	transmembrane
381	412	non-cytoplasmic
413	431	transmembrane
432	461	cytoplasmic
462	482	transmembrane
483	496	non-cytoplasmic
497	521	transmembrane
522	528	cytoplasmic
529	548	transmembrane
549	564	non-cytoplasmic

Input:
>WP_014148243.1 NCBI__GCF_000968535.2:WP_014148243.1
MKADSFKWRMSLLALLMLCVRPGIALDESTAETADSQEVSEQQAETVLDPFADALARLIS
GSMKEREQASEQLSVTGHSEALPILEALLDGRLYALRDKQTAVIATESGQGYRIAEASTG
SDLGLVERSDLSKVNITNSLRTKLRKKISLLQLQSDDASVRLSAVNAMVKTADAKTLELL
KEYESTESDEDVLSSMRLIFALNDLQNSDKSVRLDAMDTLKEYNSLEAYNRLSVLVEKDS
AGNFIEQDVEVRKKAQSALKKIEARLQFYNSVETMFFGLSLGAVLVLAAIGLAITFGVMG
VINMAHGELMMLGAYTTYVMQQIMPNHIGLSVILAIPAAFMISALVGVAIERGIIRFLYG
RPLETLLATFGISLFLQQTVRSIFSPLNRSVTTPEWMSGSWQINDFLSLTWNRFYIVLFC
LLVFAALLQILKKTRLGLEVRAVAQNRNMAKAMGIPTARVDAMTFGLGSGIAGVAGVALS
QITNVGPNLGQSYIVDSFMVVVFGGVGNLWGTLVAGFSLGIANKMLEPHAGAVLAKILVL
VFIILFIQKRPRGLFPQKGRAAEA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server